Vanberra Signal

Dyno Therapeutics

Curated by Signal

Provider of Ai-based data-driven adeno-associated virus (AAV) engineering

Overview

Provider of AI-based data-driven adeno-associated virus (AAV) engineering. The company is developing these vectors for safe and targeted in vivo delivery in gene therapies. The company uses a combination of next-generation DNA synthesis of various AAV capsids with high-throughput sequencing and machine learning. The company also maps the relationship between capsid sequence and function and optimizing vectors for improved therapeutic effect.

Key facts

Founded
2018

Contact

Open roles

6 roles
  • Sr. Research Associate

    Watertown, MA · On-site · Volunteer

  • Sr. Machine Learning Engineer

    Watertown, MA · On-site · Volunteer

  • Sr. Machine Learning Engineer - Machine Learning

    Watertown, MA · On-site · Volunteer

+ 3 more open roles on Signal

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • AI-driven drug discovery platform for neurological diseases based on patients biomarkers

    Life Sciences TechnologySan Francisco, United States
  • Provider of AI-based remote patient monitoring platform for cardiac health

    Life Sciences TechnologyOakland, United States
  • Wearable defibrillator

    Life Sciences TechnologyPittsburgh, United States

About Dyno Therapeutics

What does Dyno Therapeutics do?

Provider of AI-based data-driven adeno-associated virus (AAV) engineering.

Where is Dyno Therapeutics headquartered?

Dyno Therapeutics is headquartered in Cambridge, United States.

When was Dyno Therapeutics founded?

Dyno Therapeutics was founded in 2018.

Which sector is Dyno Therapeutics in?

Dyno Therapeutics operates in Life Sciences Technology.

Who are Dyno Therapeutics's competitors?

Companies similar to Dyno Therapeutics include Alto Neuroscience, Eko, and Lifecor.

Is Dyno Therapeutics hiring?

Yes. Dyno Therapeutics has 6 open roles listed on Vanberra Signal.